Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
SpringWorks Therapeutics, Inc. (SWTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/17/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 6.7% stake in SpringWorks Therapeutics, Inc. |
| 03/20/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/05/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/14/2022 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 9.3% stake in SpringWorks Therapeutics, Inc. |
| 09/13/2022 |
SC 13D/A
| BC SW, LP reports a 8% stake in SpringWorks Therapeutics, Inc. |
| 08/12/2021 |
SC 13D/A
| BC SW, LP reports a 9.8% stake in SpringWorks Therapeutics, Inc. |
| 03/11/2021 |
SC 13D/A
| BC SW, LP reports a 11.9% stake in SpringWorks Therapeutics, Inc. |
| 03/03/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/15/2020 |
SC 13D/A
| BC SW, LP reports a 15% stake in SpringWorks Therapeutics, Inc. |
| 10/13/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
|
|